MOTS C 20MG
SKU: CP_MOTS_C_20MG_3ML_VIAL
Catalog price · 1 item: US$90.00 (USD)
Product information
Nonclinical research
The cited 2026 work examined MOTS-c interactions with E. coli and MRSA membranes in laboratory systems, and MRSA infectivity in a mouse peritonitis model. Its charged and hydrophobic regions were investigated as contributors to these interactions.
The page also describes experiments in human monocyte cultures and differentiating mouse monocytes. Endogenous peptide expression responded to immune signals, while added MOTS-c changed macrophage gene-expression and metabolic profiles and bacterial-clearance measurements. These are findings from defined experimental models, not demonstrated effects of this product in people.
Specifications
| SKU | CP_MOTS_C_20MG_3ML_VIAL |
|---|---|
| CATEGORY | Research Compound |
| CAS | 1627580-64-6 |
| VIAL SIZE | 3 mL |
| FORM | LYOPHILIZED POWDER |
| MOLECULAR WEIGHT | 2174.6 g/mol |
| SEQUENCE | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg |
| MOLECULAR FORMULA | C101H152N28O22S2 |
| ITEM ID | 4315 |
| PURITY | 99%+ |
| CAS | 1627580-64-6 |
| FORM | LYOPHILIZED POWDER |
| DOSAGE | 20 MG |